⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 28, 2020TheranosticsOpen Access

A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice

Orli Thau‐Zuchman Linda Svendsen Simon C. Dyall Ursula Paredes-Esquivel Molly Rhodes John V. Priestley René G. Feichtinger Barbara Kofler Susanne Lotstra J. Martin Verkuyl Robert Hageman Laus M. Broersen Nick van Wijk José Silva Jordi L. Tremoleda Adina T. Michael‐Titus

View Full Paper

Ask AI

Bookmark

Share

Abstract

The behavioural improvement and tissue protection provide proof of principle that this new formulation has therapeutic potential in adult TBI.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thau‐Zuchman et al. (2020) studied this question.

synapsesocial.com/papers/6a70ede9c2d7c3090826fdbd https://doi.org/10.7150/thno.48995

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Piezoelectric hydrogels empowering closed-loop smart medicine: from self-powered sensing to autonomous therapyTheranostics · 2026
2The biomechanics of the gut in mechanical regulation of microbial ecology and translational opportunitiesTheranostics · 2026
3Tannic acid-serum albumin (TASA) complex maintains cell viability and protects from oxidative damage during hypothermic preservationTheranostics · 2026
4A conserved glycolytic malignant subcluster drives invasive progression through a PPIA-BSG metabolic-immune interaction in early lung adenocarcinomaTheranostics · 2026
5Engineered extracellular vesicle therapies for regulating gut immunity: advances and challengesTheranostics · 2026

A CSF ctDNA-based molecular panel for minimally invasive diagnosis of primary CNS lymphomaTheranostics · 2026
Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked PolyubiquitinationTheranostics · 2026
CCR2 deficiency protects against doxorubicin-induced cardiac dysfunction through enhanced IL12B-dependent autophagyTheranostics · 2026
DCTN2 inhibited cellular senescence through targeting TRIM21 mediated MST2 ubiquitination and activation in hepatocellular carcinomaTheranostics · 2026
NOD1 is a key mediator of atrial myopathy in heart failureTheranostics · 2026

More from Theranostics

More from Queen Mary University of London

More from Paracelsus Medical University

More from University of Roehampton

More from Nutricia Research (Netherlands)

More from Danone (Netherlands)

More from Danone Nutricia Research (Netherlands)